Adaptive Biotechnologies ADPT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$20.02M-47.4% | -$13.58M-242% | $9.55M+137% | -$25.59M+14.2% | -$29.83M+11.5% | ||
| $3.42M-9.2% | $3.77M-5.3% | $3.98M-2.5% | $4.08M-5.4% | $4.31M+7.3% | ||
| $11.93M-6.2% | $12.72M-4.1% | $13.26M-0.8% | $13.36M+10.0% | $12.15M-5.3% | ||
| -$9.54M— | $0+100% | -$7.13M+42.7% | -$12.43M+56.4% | -$28.48M-128% | ||
| $796K+25.2% | $636K+55.5% | $409K-37.6% | $655K-48.0% | $1.26M+1,474% | ||
| $9.14M— | —— | $17.28M+417% | $3.35M-86.9% | $25.57M+15.6% | ||
| $7.5M-65.4% | $21.66M+1,186% | $1.68M+4.6% | $1.61M-70.5% | $5.45M+4,192% | ||
| $7.11M-54.0% | $15.46M+30.6% | $11.84M+258% | -$7.47M-394% | $2.54M— | ||
| -$10.33M— | $0+100% | -$7.54M+42.4% | -$13.09M+56.0% | -$29.74M-137% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Adaptive Biotechnologies generate?
- Adaptive Biotechnologies (ADPT) generated -$29.1M in operating cash flow over the trailing twelve months.
- What is Adaptive Biotechnologies's free cash flow?
- After $2.5M of capital expenditures, Adaptive Biotechnologies's free cash flow was -$31.0M over the trailing twelve months, up 65.1% year over year.
- Where does Adaptive Biotechnologies's cash flow data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
